Find Academic Supervisors

Claus Lamm is a Full Professor of Biological Psychology at the University of Vienna , where he leads the Social, Cognitive and Affective Neuroscience Unit (SCAN-Unit) . He serves as Vice Dean for Research and Advancement of Early Career Researchers at the Faculty of Psychology and holds affiliations with the Vienna Cognitive Science Hub , Environment & Climate Change Hub , and Austrian Academy of Sciences . His academic career spans international collaborations and formative research experience abroad. Scientific Focus: Lamm investigates the neural underpinnings of empathy and prosocial behavior , employing multi-modal approaches combining neuroimaging, psychopharmacology, and psychoneuroendocrinology . His work extends to comparative studies with ravens and dogs, and explores environmental social neuroscience through climate change decision-making research. Recent publications show trends in cross-cultural psychology , machine learning applications , and neurobiological pathways related to social behavior. Awards & Grants: Recipient of the APS Mentor Award for his support of early career researchers. Funded by European Research Council , Austrian Science Fund , Vienna Science and Technology Fund , and intramural grants exceeding €10 million. Key projects include "Unravelling the opioid system in empathy" and "Comparative dog-human fMRI" . Media Engagement: A prominent public science communicator, Lamm has appeared in Nature , Science Magazine , and Austrian media outlets like Ö1 Mittagsjournal and ORF2 , discussing topics from pandemic psychology to social media effects . He maintains active outreach through Science TV and educational programs .

• Empathy
• Prosocial Behavior
• Social Neuroscience
• +5 more

Nikolaus (Nik) Fortelny is a Group Leader in Computational Biology at the University of Salzburg, Austria, where he leads the Computational Systems Biology research group within the Department of Biological Sciences & Medical Biology. His research focuses on understanding biological systems at the molecular level through advanced computational approaches. Dr. Fortelny's research interests include: Computational Systems Biology Multi-omics data integration and analysis Single-cell and spatial biology Machine learning applications in biology Network science approaches to biological regulation Immune system modeling His recent publications demonstrate a strong focus on applying computational approaches to understand complex biological systems, particularly in immunology and cellular regulation. His work often involves collaboration with experimental biologists to generate and analyze large-scale datasets from multi-omics experiments collected at single-cell or spatial resolution. Dr. Fortelny is actively involved in research recruitment and is currently hiring for professor positions in Medical Systems Biology and Animal Physiology at the University of Salzburg, with an application deadline of April 19th, 2025. His group regularly seeks students, PhD candidates, postdocs, and staff scientists to join their team.

• Computational Systems Biology
• Multi-omics Data Analysis
• Single-cell Sequencing
• +5 more

Samuli Ripatti is a Professor of Biometry in the Department of Public Health at the University of Helsinki's Faculty of Medicine. He serves as Director of the Institute for Molecular Medicine Finland (FIMM) since 2023 and leads the Academy of Finland's Center of Excellence in Complex Disease Genetics. His research integrates genetics, statistics, and clinical medicine to advance understanding of cardiometabolic diseases and genomic risk prediction. Education: Statistics major, University of Helsinki PhD in Mathematical Statistics, Stockholm University (2002) Docent in Statistics, University of Helsinki (2007) Research interests focus on cardiometabolic diseases, polygenic risk scores (PRS), and genetic epidemiology. He has pioneered PRS for disease prevention and developed clinical risk algorithms, with applications in precision medicine and global health initiatives. Recent publications highlight trends in polygenic risk modeling across diverse diseases, lipidomics, sleep disorders, and trauma outcomes. His work spans genomics, bioinformatics, and translational medicine. Scientific awards: Knight, First Class, of the Order of the White Rose of Finland (2021) Highly Cited Researcher (2018, 2017, 2016) Ripatti chairs doctoral programs in life sciences and the EU-funded INTERVENE project, which develops genomic risk prediction methods. He has led research groups at FIMM-EMBL, the Broad Institute, and the Wellcome Trust Sanger Institute. As Director of FIMM and member of scientific advisory boards (e.g., NMRC Singapore, EXCEED), he shapes global genomic research collaborations and biobank infrastructure.

• Genetic epidemiology
• Statistical genetics
• Human genetics
• +5 more

Corinna Brungs is a Senior Scientist at the University of Vienna , affiliated with the Faculty of Life Sciences and the Department of Pharmaceutical Sciences (Division of Pharmacognosy). Her research focuses on applying cutting-edge mass spectrometry techniques for natural product identification, biomarker discovery, and untargeted metabolomics workflows. Developing open mass spectral libraries Advancing data processing strategies Specializing in tattoo pigment and metabolite analysis Research Highlights: Brungs bridges phytochemistry and computational metabolomics through method development in mass spectrometry. Her work includes creating standardized protocols for: Tattoo pigment identification In-source fragmentation analysis Non-targeted drug exposure profiling Integration of mobility-resolved spectrometry Scientific Awards: 2025 Early Career Prize (Metabolomics Society) 2025 Early Career Travel Award (Metabolomics Society) 2022 Czech Academy of Sciences Fellowship Publications (2022-2025) demonstrate leadership in: MALDI-TIMS-MS2 bioimaging MZmine 3 software development Metabolomics data reproducibility Mass spectral library matching

• Phytochemistry
• Biodiscovery
• Mass Spectrometry
• +4 more

Jörg Menche holds a full Professor position (Univ.-Prof.) at the University of Vienna, with dual appointments in the Faculty of Mathematics, Department of Mathematics, and Max Perutz Labs, Department of Structural and Computational Biology. His work bridges mathematical modeling and biomedical research through network-based approaches to complex disease mechanisms. Primary research interests include Network Biology, Computational Systems Medicine, and Immunometabolism, with specific focus on proteomic signatures in neuropathic pain, metabolic reprogramming in obesity, and autoimmunity networks. He develops innovative computational tools like VRNetzer for virtual reality network analysis and BioProfiling.jl for high-content imaging data integration, targeting intersections between metabolism, immunity, and environmental exposures. Recent publications (2019-2024) reveal a dominant trend in multi-omics network medicine, particularly in autoimmunity (AutoCore framework), cardiometabolic diseases, and rare genetic disorders. His work demonstrates exceptional translational impact, with multiple papers highlighted by news outlets and patents (e.g., 3 patents referencing 2021 research). While the text indicates involvement in one project (2016) and 13 activities, grant specifics and student mentoring details remain undisclosed. His collaborative network spans immunology, neuroscience, and toxicology, evidenced by co-authorships with clinical and computational teams. Menche operates within Max Perutz Labs, a premier molecular biology research center in Vienna. His team integrates computational biologists, cell biologists, and clinicians to develop network cartography methods for disease module identification, with strong emphasis on virtual reality interfaces and multi-omics validation.

• Network Biology
• Computational Systems Medicine
• Proteomics
• +4 more

Markus Teige is a researcher at the Max Perutz Labs, affiliated with the Faculty of Life Sciences at the University of Vienna, in the Department of Biochemistry and Cell Biology. His work focuses on plant stress tolerance, calcium signaling, chloroplast development, protein phosphorylation, and organelle signaling networks. Current projects include Molecular mechanisms of plant stress tolerance (2021–2025) and Calcium regulation of chloroplast development & function (ongoing). Past projects include Auswirkungen von Virusinfektionen auf die Kalziumhomöostase (2020–2022). Research trends from his 62 publications emphasize calcium signaling in plant antiviral defense, chloroplast stress responses, and integrated multi-omics approaches to abiotic stress in crops like potato. His work bridges organelle physiology with whole-plant stress adaptation. Teige collaborates internationally on plant signaling and systems biology, contributing to Sustainable Development Goals (SDGs) related to climate-resilient agriculture and stress biology.

• Plant Stress Tolerance
• Calcium Signaling
• Chloroplast Development
• +5 more

Terho Lehtimäki is a Professor and Head of the Department of Clinical Chemistry at Tampere University's Faculty of Medicine and Health Technology. He also serves as Chief Physician at Fimlab Laboratories, a major clinical laboratory in Finland. His academic roles include being a docent in medical biochemistry and clinical chemistry, and he holds an eMBA degree. His research focuses on cardiovascular disease biomarkers, atherosclerosis, omics technologies, and genetic/epigenetic factors influencing complex traits. He leads major studies like the Tampere Vascular Study and contributes to over 35 international consortia. With 1200+ peer-reviewed publications and an H-index of 147, his work has driven discoveries in over 5000 genetic variants. Notable recognitions include membership in Academia Europaea and the University of Tampere Science Prize. Education & Career MD/PhD (1992) Docent in Medical Biochemistry (1996, University of Tampere) Docent in Clinical Chemistry (2003, University of Eastern Finland) eMBA (2013) Research Interests Cardiovascular biomarkers for risk prediction Omics-based systems biology approaches Functional genetics of complex traits Epigenetic inheritance mechanisms Multimodal cohort studies (e.g., Young Finns Study) Publications & Impact His work spans Nature, Science, and NEJM, with key contributions to understanding atherosclerosis biology, genetic risk factors, and clinical translation of omics data. Recent trends emphasize multi-omics integration and precision medicine applications. Awards & Leadership Over €15M in grant funding 3 spin-off companies Scientific leadership roles in >35 international initiatives Reviewer for 50+ journals and 15 funding agencies Teaching & Mentorship Trained over 60 PhD/MSc students, many now leading academic and clinical roles. Active in problem-based learning methodologies at Tampere University's Center of Excellence. Labs & Teams Directs the Clinical Chemistry Department's research group, collaborating closely with Fimlab Laboratories and international networks like the European Eye Consortium.

• Atherosclerosis biomarkers
• Clinical Chemistry
• Genetics
• +7 more

Martin Turner is a Research Fellow at the University of Cambridge , affiliated with the Cambridge Stem Cell Institute and Immunology Programme . His work focuses on post-transcriptional gene regulation in lymphocytes. First systematic application of molecular biology to cytokine gene expression in human immune cells Defined phosphoinositide 3-kinase roles in lymphocyte development Instrumental in microRNA-155 biology research Developed cutting-edge methods like iCLIP and ribosome profiling His research combines mouse genetics with multiomics to study RNA binding proteins' regulatory roles in B-cell diseases and immune responses . Collaborative work with ICOS Corporation established PI3K inhibition rationale. 2016 Wellcome Investigator awardee 2007 MRC Senior Non-Clinical Fellowship recipient 2005 Research Council Individual Merit promotion Publications reveal expertise in RNA-protein interactions and lymphocyte signaling pathways , with recent work on translational control and multi-omics integration . Leads a team of 12 researchers including PhD students and postdocs at The Babraham Institute .

• Functional genomics
• Signal transduction
• Mouse models
• +6 more

Christophe Tzourio is a Professor of Epidemiology at the University of Bordeaux and Co-director of the National Inserm School since 2023. He has led major research centers including the Bordeaux Population Health Research Center (Inserm U1219) since 2013, overseeing 13 teams and over 450 staff. His academic career spans roles at Inserm, Paris VI, and international visiting positions in Australia and New Zealand. Academic Rank: Professor Key Affiliations: Inserm, University of Bordeaux His research focuses on neuroepidemiology , particularly the consequences of hypertension on brain health , dilated perivascular spaces , and vascular brain lesions . He pioneered population-based cohort studies like the 3C Study (9,293 participants) and the i-Share e-cohort (16,000+ students) to investigate brain maturation and mental health. His work integrates big data , clinical trials , and digital public health methodologies. Recent publications highlight his contributions to stroke genetics , Alzheimer's disease etiology , and brain imaging biomarkers . Collaborative projects like the LEOPOLD trial and the Leducq Transatlantic Network demonstrate his impact on hypertension-related stroke prevention and vascular cognitive disorders. He serves on scientific committees for Public Health France and major journals like JAMA and Lancet . Scientific Awards: 2020-2024: French Ministry of Research - Award for Scientific Excellency 2012: Fondation Bettencourt Prize (€250,000) 2007: Founding Member, VASCOG

• Neuroepidemiology
• Consequences of hypertension on the brain
• Students’ mental health
• +4 more

Viktoria Dorfer is a Professor at the University of Applied Sciences Hagenberg, affiliated with the Bioinformatics Center of Excellence and Medical Engineering/TIMed Center HEAL. She holds an ORCID iD (0000-0002-5332-5701) and has published 66 research outputs with an h-index of 9 and 676 citations. 2007–2012: Doctoral research on algorithmic approaches 2013–2016: FWF Translational Research on MS Amanda 2020–2022: PI for b-tastic project Research Interests: Spanning bioinformatics, mass spectrometry, and medical engineering, her work focuses on: Algorithm development for peptide identification Evolutionary algorithms in data analysis Mass spectrometry software platforms (AMANDA, Annika) Cross-linked peptide analysis Precision agriculture applications Medical device optimization 2024 Trends: Recent contributions include symbolic regression in livestock farming, enhanced rescoring platforms, and structural analysis of the C. elegans Box C/D complex. Awards: EuPA Bioinformatics Mass Spectrometry Award (2020) Leadership: Organized Austrian Proteomic Research Symposia (2017), served as reviewer/peer-reviewer for journals, and led interdisciplinary collaborations.

• Bioinformatics
• Mass Spectrometry
• Machine Learning
• +7 more

Jacques Colinge serves as an Associate Professor at the Institute of Neural Engineering, specializing in interdisciplinary research at the intersection of computational methods and biological systems. His primary affiliation centers on advancing neural engineering applications through bioinformatics frameworks. His research focuses on computational biology and neural engineering, emphasizing data integration techniques for complex biological networks. Key interests include developing bioinformatics tools for genomics and proteomics analysis, systems biology modeling, and creating collaborative infrastructure for multi-omics data processing. This work bridges engineering principles with life sciences to solve high-dimensional biological challenges. Between 2010 and 2012, Colinge contributed to the Bioinformatics Integration Network III project through three sequential reports documenting the project's progression. These publications reveal a consistent trajectory in building computational frameworks for biological data harmonization, with increasing sophistication in network analysis methodologies and tool development across the reporting period. Colinge operates within a collaborative research ecosystem at the Institute of Neural Engineering, working alongside specialists including Thallinger, Stark, Novatchkova, von Haeseler, Hofacker, Djinovic-Carugo, Bennett, Baumgartner, Graber, and Trajanoski. This team structure facilitates cross-disciplinary innovation in bioinformatics infrastructure development.

• Bioinformatics
• Neural Engineering
• Computational Biology
• +2 more

Palak Chaturvedi is a researcher at the Faculty of Life Sciences, specializing in Functional and Evolutionary Ecology. Her work focuses on plant stress physiology, metabolomics, and multi-omics approaches to sustainable agriculture. Fields of Interest: Plant Biochemistry, Metabolomics, Stress Physiology, Microbial Ecology Her research explores biological nitrification inhibition, root exudate dynamics, and genomic responses to abiotic stresses like heat and drought. Key themes include crop improvement, plant-microbe interactions, and climate-resilient agroecosystems. Recent publications emphasize multi-stress tolerance in crops, metabolic profiling, and evolutionary adaptations in plants. She employs systems biology and omics technologies to decode stress mechanisms across species like wheat, potato, and millets. Scientific Awards: Young Investigator Award (2019) Palak collaborates on projects related to biological nitrogen fixation, soil microbiome, and climate-proof crops, contributing to global Sustainable Development Goals in agriculture and environmental protection.

• Plant Biochemistry
• Molecular Ecology
• Stress Physiology
• +3 more

Barbara Steiner is a Senior Scientist at the Institute of Crop Breeding and Genomics, University of Natural Resources and Life Sciences, Vienna (BOKU). Her research focuses on enhancing resistance to Fusarium head blight (FHB) in wheat through advanced genomic and breeding approaches, addressing critical food safety concerns related to mycotoxin contamination. Her primary research interests encompass plant breeding, crop genomics, and the genetic dissection of Fusarium resistance in cereals. She investigates quantitative trait loci (QTL), the role of plant morphology in disease resistance, and mycotoxin detoxification mechanisms. Her work has pioneered the functional characterization of resistance genes like UDP-glucosyltransferases and the pyramiding of QTLs from wild relatives into cultivated wheat. Analysis of her recent publications reveals a strong trend toward integrating multi-omics data (genomics, transcriptomics) for predicting FHB resistance and developing genomic selection tools. She has made significant contributions to understanding the genetic architecture of resistance in durum and bread wheat, with emphasis on practical breeding applications for reducing mycotoxin accumulation in grain.

• Plant Breeding
• Crop Genomics
• Wheat Genetics
• +3 more

Jürgen Zanghellini is a Professor at the Faculty of Chemistry, Institute of Analytical Chemistry. His work spans metabolic engineering, bioprocess optimization, and proteomics, with a focus on industrial microorganisms like Escherichia coli and Komagataella phaffii. Key Projects : Circular Bioengineering (2024-2029) Prokaryote Proteomics at High Temperatures (2024-2027) Morphometabolic Fingerprint of Ovarian Cancer (2022-2026) Research Themes : Metabolic modeling, crosslinking mass spectrometry, and data-driven bioprocess control dominate his recent work. He integrates multi-omics approaches to enhance viral vector yields and optimize fed-batch fermentation processes. Collaborations : He works extensively with researchers like Köllensperger, Gerner, and Mattanovich, and is involved in organizing scientific events such as 'The Metabolic Guide to Space Survival' (2025).

• Metabolic Engineering
• Bioprocess Optimization
• Proteomics
• +3 more

Professor Ann Daly is a distinguished researcher and academic at Newcastle University's Faculty of Medical Sciences, where she serves as Professor of Pharmacogenetics within the Translational and Clinical Research Institute. With over 40 years of academic experience at Newcastle University, she has established herself as a leading expert in pharmacogenetics, particularly focusing on liver disease and drug-induced liver injury. Her research has significant implications for personalized medicine and clinical pharmacology. Professor Daly completed her BA and PhD in Biochemistry at the University of Dublin in 1978 and 1982 respectively. She conducted postdoctoral research at the University of Geneva and Trinity College Dublin before joining Newcastle University, where she progressed from Research Associate to her current Professorial position. She was elected Fellow of the British Pharmacological Society in 2012 and became a Member of Academia Europaea in 2023. Her research interests center on pharmacogenetic studies of novel human genetic polymorphisms, their functional significance, and relationship to drug therapy outcomes, adverse drug reactions, and liver diseases. She coordinates the iDILIC network on genetics of drug-induced liver injury and contributes to several major international projects including TransBioLine, LITMUS, GenomALC, and OPPM. Her work bridges fundamental genetic research with clinical applications to develop personalized treatment approaches. Analysis of her recent publications reveals a strong focus on non-alcoholic fatty liver disease (NAFLD) and metabolic dysfunction-associated steatotic liver disease (MASLD), with particular emphasis on genetic and molecular mechanisms, biomarker discovery, and the role of pharmacogenomics in understanding disease progression and treatment response. Her research increasingly incorporates multi-omics approaches, integrating transcriptomic, proteomic, and metabolomic data to understand complex disease pathways. 2019 American Association for the Study of the Liver. Hyman J. Zimmerman Hepatotoxicity State-of-the-Art Lecture 2017 International Society for the Study of Xenobiotics (ISSX), Award for Major Scientific Contributions in the field of Xenobiotics in the European Region 2012 Fellow of the British Pharmacological Society 2009 British Pharmacological Society Australasian Visitor scholarship Professor Daly actively contributes to the scientific community through leadership roles including Chair of the European Society of Pharmacogenomics and Personalised Therapy (2023-2024), Vice-chair of the IUPHAR Pharmacogenetics subcommittee (2018-2023), and membership on the Pharmacovigilance Expert Advisory Group for the Commission on Human Medicines, MHRA. She serves as Senior Editor for the British Journal of Clinical Pharmacology and on the editorial boards of several leading pharmacology journals. Her research is supported by multiple international collaborations and funding sources focused on translating genetic discoveries into clinical practice.

• Pharmacogenomics
• Liver Disease
• Drug-Induced Liver Injury
• +7 more